Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma
<p>Abstract</p> <p>Background</p> <p>Detection of circulating malignant cells (CMCs) through a reverse transcriptase-polymerase chain reaction (RT-PCR) assay seems to be a demonstration of systemic disease. We here evaluated the prognostic role of RT-PCR assays in seria...
Main Authors: | Daponte Antonio, Simeone Ester, Caracò Corrado, Canzanella Sergio, Tanda Francesco, Cossu Antonio, Budroni Mario, Satriano Sabrina MR, Palmieri Giuseppe, Mozzillo Nicola, Comella Giuseppe, Castello Giuseppe, Ascierto Paolo A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-11-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/6/266 |
Similar Items
-
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy
by: Canzanella Sergio, et al.
Published: (2009-10-01) -
Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatment
by: Ascierto Paolo A, et al.
Published: (2010-08-01) -
Effect of dabrafenib on melanoma cell lines harbouring the BRAF<sup><it>V600D/R</it></sup> mutations
by: Gentilcore Giusy, et al.
Published: (2013-01-01) -
Perivascular Epithelioid Cell Tumors (PEComas) of the Orbit
by: Panagiotis Paliogiannis, et al.
Published: (2017-01-01) -
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
by: Mariaelena Capone, et al.
Published: (2018-07-01)